Pituitary Apoplexy in the Setting of COVID-19 Infection: A Case Report

Abstract

Coronavirus disease 2019 (COVID-19) is primarily a febrile respiratory illness first documented in December 2019 in Wuhan, China that was declared a pandemic by the World Health Organization (WHO) on March 11, 2020. At the time of this writing COVID 19 infections have impacted 191 counties, and the death toll stands at 1,488,513. COVID-19 infection is known to cause coagulopathy and an inflammatory state, but there are few case reports involving COVID-19 related spontaneous bleeding outside of disseminated intravascular coagulation. To date there has only been a single case report of pituitary apoplexy in the setting of COVID-19; this was in a pregnant woman, which is a known risk factor for apoplexy. Here, we present a case of pituitary apoplexy in the setting of COVID-19 infection with no such risk factors.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Feb 23, 2021
Accession Number
AD1125243

Entities

People

  • Michael Laroy
  • Morgan Mcguire

Organizations

  • Naval Medical Center San Diego

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Blood
  • Cardiovascular Physiological Phenomena
  • Cerebrovascular Disorders
  • Covid-19
  • Department Of Defense
  • Disease Outbreaks
  • Emergencies
  • Emergency Medicine
  • Governments
  • Health Services
  • Heart Rate
  • Hematologic Diseases
  • Hemorrhage
  • Infection
  • Pain
  • Peripheral Nervous System
  • Respiratory Tract Diseases
  • Risk Factors
  • United States
  • United States Government
  • Wound Infections

Fields of Study

  • Medicine

Readers

  • Infectious Disease/Epidemiology
  • Trauma Surgery or Emergency Medicine.